Fluvoxamine Lawsuit

What is Fluvoxamine?

Fluvoxamine, which goes by the brand name Luvox, is a drug used to treat obsessive-compulsive disorder (bothersome thoughts that are persistent and only go away after performing necessary functions over and over) and social anxiety disorder (extreme fear of interacting with other people or performing in front of people). Fluvoxamine is part of a class of medications called selective serotonin reuptake inhibitors. It is effective by increasing serotonin in the brain; serotonin helps maintain mental balance.

Fluvoxamine comes as a tablet (in both regular and extended-release form). Taken once or twice a day, Fluvoxamine is an oral drug that is attached with a bevy of warnings and Fluvoxamine side effects.

Fluvoxamine Side Effects:

Fluvoxamine side effects are affirmed on the label’s packaging. Please inform your doctor if any of these adverse reactions are severe or persistent:

• Fluvoxamine side effects include drowsiness, difficulty concentrating, confusion and memory problems.

• Dry mouth, headache, vomiting, nausea and diarrhea are common Fluvoxamine side effects.

• Constipation, gas and indigestion may be experienced as Fluvoxamine side effects.

• Change in taste, decreased appetite, weight loss and weakness may be experienced as Fluvoxamine side effects.

• Nervousness, unsteadiness and changes in sex drive or ability are common Fluvoxamine side effects

Some Fluvoxamine side effects are regarded as more severe. Please contact your doctor if you experience any severe Fluvoxamine side effects or symptoms or those labeled on the drug’s IMPORTANT WARNING section. Examples of severe Fluvoxamine side effects include:

• Chest pains

• Problems with coordination

• Dizziness

• Hallucinations are regarded as severe Fluvoxamine side effects

• Fever, confusion, sweating alterations in heartbeat and severe muscle stiffness are deemed severe Fluvoxamine side effects

• Burning, pain, numbness or tingling of the hands and feet are regarded as severe Fluvoxamine side effects

• Unusual bruising, bleeding, red blood in stool and loss of consciousness are also classified as severe Fluvoxamine side effects

If you experience any of the above serious Fluvoxamine side affects you or your medical professional should file a report with the Food and Drug Administration’s MedWatch Adverse Event Reporting program located at 1-800-332-1088 or online at http://www.fda.gov/Safety/MedWatch.

Fluvoxamine Lawsuits:

Fluvoxamine is classified as a Selective Serotonin Reuptake Inhibitor; these drugs are prescribed to treat patients suffering from obsessive-compulsive disorder. Fluvoxamine, which is still on the market, is attached with numerous FDA mandated box regarding to promulgate the inherent dangers of the drug, primarily suicidal thoughts and behavior. The United States Food and Drug Administration also issued a number of other warnings concerning Fluvoxamine, which if not adhered to, may jeopardize the lives of users.

The prominent risk associated with Fluvoxamine is increased risk of suicide. Additional concerns cite medical complications, such as serotonin syndrome, as other grounds for Fluvoxamine lawsuits.

Fluvoxamine lawsuits are typically grouped into other class-action suits involving similar SSRI drugs that bring to harm to users. Patients taking Fluvoxamine that experience suicidal thoughts or abnormal behavior that results in damage should consult with legal specialists to initiate a Fluvoxamine lawsuit.

Victims of the drug are encouraged to file a Fluvoxamine lawsuit to attain a Fluvoxamine settlement. Fluvoxamine settlements are used to offset the costs associated with the injury or death stemming from Fluvoxamine-use. A Fluvoxamine settlement will be used to help swallow the financial and emotional costs of the injury or death.
In addition to suicidal thoughts and actions, Fluvoxamine lawsuits are commonly filed for birth defects. On July 4th of 2011 a study announced that children born to mothers who use Fluvoxamine face an increased risk of developing several birth defects, including autism-spectrum disorders. If you used Fluvoxamine while pregnant, you should immediately contact a drug or product liability lawyer to initiate a Fluvoxamine lawsuit.

Fluvoxamine lawsuits stem from an FDA Alert that was issued during the summer of 2006. This particular FDA warning pointed to the increased risk of Neonatal Persistent Pulmonary Hypertension to babies born to mothers using Fluvoxamine. Since this warning, a plethora of information is emerging linking several SSRI’s to the cause of such birth defects as autism, craniosynostosis, club foot and anal atresia.

If you or your baby suffered as a result of Fluvoxamine-use, it is vital that you speak with an experienced drug or personal injury attorney to being filing a Fluvoxamine lawsuit. The inclusion of an experienced attorney will ultimately bolster your odds of securing a Fluvoxamine settlement.

Recent Fluvoxamine Settlements:

Fluvoxamine settlements are filed by former users who suffer one of the aforementioned Fluvoxamine side effects. Fluvoxamine lawsuits seek Fluvoxamine settlements; a Fluvoxamine settlement may be filed to retrieve compensation for the following:

• Fluvoxamine lawsuits may be filed to retrieve economic damages

• Fluvoxamine lawsuits may be filed to receive end-of-life expenses or exemplary damages

• A Fluvoxamine settlement may include loss of benefits, consortium, earning capacity, wages and/or parental care

• A Fluvoxamine settlement may include compensation for medical costs and punitive damages

• Fluvoxamine settlements may include compensation for loss of spousal support and companionship

• Fluvoxamine settlements may include compensation for non-economic damages


Sources:

1.United States National Library of Medicine “Fluvoxamine” retrieved from:

http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000955/

2. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022033s007lbl.pdf

3.http://www.fda.gov/Safety/MedWatch/SafetyInformation/

Safety-RelatedDrugLabelingChanges/ucm117747.htm

4.http://www.fda.gov/Drugs/DrugSafety/

PostmarketDrugSafetyInformationforPatientsandProviders/ucm113425.htm